This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
The Robots Are Leaving the Lab and They're Ready for the Real World
Jeff Burnstein, President of the Association for Advancing Automation (A3), discusses humanoid robots, AI, smart manufacturing, and the future of U.S. industry.
Is This the Beginning of the End for Under-16s on Social Media?
Should kids be banned from social media? Nick Lichtenberg of Fortune breaks down the global push to restrict under-16 users and what it means for Big Tech.
Google, Netflix & A24 Are Betting Big on AI: Should Hollywood Be Worried?
Corbin Bolies of Variety explains how AI is reshaping Hollywood, from Google's A24 partnership to Netflix's major investment in AI filmmaking.
Meet the AI Robot That's Taking Over the Most Dangerous Job in Restaurants
Miso Robotics CEO Rich Hull discusses Flippy Fry Station, the future of AI-powered restaurant automation and how acquiring Zume's IP could reshape food robotics
The AI Boom's Next Reckoning: Wall Street Wants Profits, Not Promises
After two years of AI-fueled spending, Wall Street is asking what's next. Gil Luria breaks down monetization, valuations, winners, losers, and AI's future.
Meet the AI Designed for Mental Health, Not Just Conversation
Talkspace CEO Dr. Jon Cohen joins us to explain TEE, the rise of AI for emotional support, and the future of digital mental health care.
